Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy

Clinical trial NCT01947569 · UNKNOWN

Trial details

NCT number: NCT01947569
Sponsor: DiaVacs, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Treatment of Type I Diabetes Mellitus.

Start date: 2013-10-01
Primary completion: 2014-11-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.